Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh

George Tidmarsh, new Senior Editor on Disease Models & Mechanisms (DMM), is a physician with an academic science and medicine background and over two decades of industry experience at the cutting edge of biotechnology and drug development. Currently CEO of La Jolla Pharmaceutical Company Inc. as...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Limited 2013
Materias:
A Model for Life
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701206/
https://www.ncbi.nlm.nih.gov/pubmed/23828643
http://dx.doi.org/10.1242/dmm.012997
_version_ 1782275607322689536
collection PubMed
description George Tidmarsh, new Senior Editor on Disease Models & Mechanisms (DMM), is a physician with an academic science and medicine background and over two decades of industry experience at the cutting edge of biotechnology and drug development. Currently CEO of La Jolla Pharmaceutical Company Inc. as well as Consulting Associate Professor at Stanford University School of Medicine, he provides an insight into the value of industry as a conduit between academic research and patient benefit.
format Online
Article
Text
id pubmed-3701206
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Company of Biologists Limited
record_format MEDLINE/PubMed
spelling pubmed-37012062013-07-15 Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh Dis Model Mech A Model for Life George Tidmarsh, new Senior Editor on Disease Models & Mechanisms (DMM), is a physician with an academic science and medicine background and over two decades of industry experience at the cutting edge of biotechnology and drug development. Currently CEO of La Jolla Pharmaceutical Company Inc. as well as Consulting Associate Professor at Stanford University School of Medicine, he provides an insight into the value of industry as a conduit between academic research and patient benefit. The Company of Biologists Limited 2013-07 /pmc/articles/PMC3701206/ /pubmed/23828643 http://dx.doi.org/10.1242/dmm.012997 Text en © 2013. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle A Model for Life
Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title_full Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title_fullStr Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title_full_unstemmed Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title_short Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh
title_sort linking academia and industry to bring drugs to the clinic: an interview with george tidmarsh
topic A Model for Life
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701206/
https://www.ncbi.nlm.nih.gov/pubmed/23828643
http://dx.doi.org/10.1242/dmm.012997

Ejemplares similares